| Theme | Colorectal cancer screening and surveillance -- Prospects towards standardization from new findings | |
|---|---|---|
| Title | Colorectal cancer screening in the US; Current consensus and future directions | |
| Publish Date | 2021/05 | |
| Author | Yutaka Tomizawa | Division of Gastroenterology and Hepatology, University of Washington, USA |
| [ Summary ] | Colorectal cancer (CRC) remains the third most common cancer as well as the third leading cause of cancer deaths in both men and women in the U.S. Given the difficulty in widespread primary prevention strategies to decrease CRC risk, screening with either colonoscopy or fecal immunochemical test (FIT) is considered the most powerful public health tool to reduce the CRC mortality. USMSTF (United States Multi-Society Task Force) and USPSTF (United States Preventative Service Task Force) both recommends screening for CRC starting at age 50 years. Despite of lack of the national health insurance system in US, the majority of health insurances approve the CRC screening tests at age of 50 years. Growing evidence also has suggested the increasing incidence of CRC in people younger than 50 years, which has raised awareness of the importance of risk stratification for CRC screening in US. | |